Summary
Delayed-type hypersensitivity (DTH) to the chemically induced EL4 and virally induced ARadLV 136 leukemia cells was determined by the radioactive ear test. Prior to the DTH test, mice were prevaccinated with cells treated either with hydrostatic pressure or with the membrane-impermeant crosslinker adenosine dialdehyde or with a combination of these. For both tumor cells, DTH against unmodified cells was markedly potentiated by prevaccination with cells treated with hydrostatic pressure combined with adenosine dialdehyde. In vitro cytotoxicity data indicated that maximal lysis of target cells is induced by vaccination with adenosine-dialdehyde-treated cells, as well as by pressure in combination with adenosine dialdehyde treatment. In addition, increased [3H]thymidine uptake was observed in effector T cells induced by prevaccination with tumor cells modified by adenosine dialdehyde or pressure or both. This novel and innocuous potentiation of an antitumor immune response may have a practical utility in the treatment of human cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brunner TK, Engers HD, Cerottini JC (1976) The51Cr release assay as used for the quantitative measurement of cell-mediated cytolysis in vitro. In: Bloom BR and David JR (eds) In vitro methods in cell-mediated and tumor immunity. Academic Press, London, p 423
Crowle AJ (1975) Delayed hypersensitivity in the mouse. Adv Immunol 20: 197
Deckmann M, Haimovitz R, Shinitzky M (1985) Selective release of integral proteins from human erythrocyte membranes by hydrostatic pressure. Biochim Biophys Acta 821: 334
Gorer PA (1961) The isoantigens of malignant cells. In: Harris RJC (ed) Biological approaches to cancer chemotherapy. Academic Press, New York, p 219
Hansske F, Sprinzl M, Cramer F (1974) Reaction of the ribose moiety of adenosine and AMP with periodate and carboxylic acid hydrazides. Bioorg Chem 3: 367
Haran-Ghera N, Ben-Yorakov M, Peled A (1977) Immunological characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants: I. Cellular analysis of immunosuppression. J Immunol 118: 600
Hawrylko E (1980) Induction of delayed-type hypersensitivity and anti-tumor immunity by systemic BCG. Cell Immunol 50: 136
Hoover HC, Surdyke M, Dargel RB, Peters LC, Hanna MG (1984) Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: bacillus Calmette-Guérin vaccine. Cancer Res 44: 1671
Knulst AC, Berends D, Bazuin C, van Rooij HCJ, de Both NJ, Benner R (1989) Enhancement and suppression of DTH reactivity to Rauscher murine leukaemia virus induced tumor cell lines. Br J Cancer 60: 351
LeFever AV, Killion JJ, Kollmorgen GM (1976) Active immunotherapy of L1210 leukemia with neuraminidase-treated drugresistant L1210 sublines. Cancer Immunol Immunother 1: 211
Lider O, Shinitzky M, Cohen IR (1986) Vaccination against experimental autoimmune diseases using T-lymphocytes treated with hydrostatic pressure. Proc NY Acad Sci 275: 267
Lider O, Karin N, Shinitzky M, Cohen IR (1988) Therapeutic vaccination against adjuvant arthritis using autoimmune T-cells treated with hydrostatic pressure. Proc Natl Acad Sci USA 84: 4577
Muller CP, Shinitzky M (1981) Passive shedding of erythrocyte antigens induced by membrane rigidification. Exp Cell Res 136: 53
North RJ, Awwad M, Dunn PL (1989) T cell-mediated tumor regression in experimental systems. In: Melchers F et al. (eds) Progress in immunology — Proceedings of the 7th International Congress of Immunology, Berlin 1989, vol 7. Springer-Verlag, Berlin, Heidelberg, New York, p 1097
Old LJ (1989) Structural basis for tumor cell recognition by the immune system. In: Melchers F et al. (eds) Progress in immunology — Proceedings of the 7th International Congress of Immunology, Berlin 1989, vol 7. Springer-Verlag, Berlin, Heidelberg, New York, p 1053
Prager MD, Baechtel SF (1973) Methods for modification of cancer cells to enhance their antigenicity. Methods Cancer Res 9: 339
Richert L, Or A, Shinitzky M (1986) Promotion of tumor antigenicity in EL4 leukemia cells by hydrostatic pressure. Cancer Immunol Immunother 22: 119
Rios A, Simmons RL (1973) Immunospecific regression of various syngeneic mouse tumors in response to neuraminidase-treated tumor cells. J Natl Cancer Inst 51: 637
Sedlacek HH, Bengelsdorff KH, Hagmayer G, Seiler FR (1987) Tumor therapy of neoplastic disease with tumor cells and neuraminidase: experimental studies on chessboard vaccination in transplantation tumors. Int J Immunopharmacol 9: 841
Shinitzky M, Skornick Y (1990) Cancer immunotherapy with autogtlogous and allogeneic vaccines: a practical overview. Prog Clin Biol Res 348: 95
Shinitzky M, Souroujon M (1979) Passive modulation of bloodgroup antigens. Proc Natl Acad Sci USA 76: 4438
Skornick Y, Danciger E, Rozin RR, Shinitzky M (1981) Positive skin tests with autologous tumor cells of increased membrane viscosity: first report. Cancer Immunol Immunother 11: 93
Skornick Y, Dresdale AR, Sindelar WF (1983) Induction of delayed hypersensitivity reactions in cancer patients by cholesteryl hemisuccinate-treated autologous tumor cells. J Natl Cancer Inst 70: 465
Skornick Y, Gorelik E, Klausner J, Shinitzky M, Sindelar WF (1984) Inhibition of growth and metastases in mice by immunization with cholesteryl hemisuccinate-enriched tumor cells. Cancer Lett 25: 153
Skornick YG, Rong GH, Sindelar WF, Richert L, Klausner JM, Rozin RR, Shinitzky M (1986) Active immunotherapy of human solid tumor with autologous cells treated with cholesteryl hemisuccinate — a phase I study. Cancer 58: 650
Suda T, Fujiwara H, Mizushima Y, Shearer GM, Hamaoka T (1986) Augmentation of anti-tumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2− T-cell mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers. J Natl Cancer Inst 77: 1267
Tanake K, Hayashi H, Hamada C, Khoury G, Jay G (1986) Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells. Proc Natl Acad Sci USA 83: 8723
Vadas MA, Miller JFAP, Gamble J, Whitelaw A (1975) A radioisotopic method to measure delayed-type hypersensitivity in the mouse: I. Studies in the sensitized and normal mice. Int Arch Allergy Appl Immunol 49: 670
Vánky F, Stjernswärd J (1976) Lymphocyte stimulation test for detection of tumor-specific reactivity in humans. In: Bloom BR, David JR (eds) In vitro methods in cell-mediated and tumor immunity. Academic Press, New York, p 597
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ramakrishna, V., Shinitzky, M. Potentiation of delayed-type hypersensitivity response to syngeneic tumors in mice prevaccinated with cells modified by hydrostatic pressure and crosslinking. Cancer Immunol Immunother 33, 1–8 (1991). https://doi.org/10.1007/BF01742520
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01742520